Chronic ketamine use increases serum levels of brain-derived neurotrophic factor

被引:53
作者
Ricci, Valerio [1 ,2 ]
Martinotti, Giovanni [2 ]
Gelfo, Francesca [1 ]
Tonioni, Federico [2 ]
Caltagirone, Carlo [1 ,3 ]
Bria, Pietro [2 ]
Angelucci, Francesco [1 ]
机构
[1] IRCCS Santa Lucia Fdn, Dept Clin & Behav Neurol, I-00179 Rome, Italy
[2] Catholic Univ, Inst Psychiat, I-00168 Rome, Italy
[3] Univ Roma Tor Vergata, Dept Neurosci, I-00133 Rome, Italy
关键词
Ketamine; BDNF; Drug abuse; NGF; Serum levels; NMDA receptors; Neurotrophin; Neurotoxicity; METHYL-D-ASPARTATE; NERVE GROWTH-FACTOR; NUCLEUS-ACCUMBENS; RECEPTOR ANTAGONIST; HEALTHY-VOLUNTEERS; RAT HIPPOCAMPUS; NMDA RECEPTORS; EXPRESSION; MICE; BDNF;
D O I
10.1007/s00213-010-2121-3
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Ketamine is a non-competitive N-methyl-d-aspartate (NMDA) receptor antagonist which interferes with the action of excitatory amino acids (EAAs) including glutamate and aspartate. The use of ketamine at subanaesthetic doses has increased because of its psychotomimetic properties. However, long-term ketamine abuse may interfere with memory processes and inhibit the induction of long-term potentiation (LTP) in the hippocampus, an effect probably mediated by its NMDA antagonist action. Neurotrophins such as brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) serve as survival factors for selected populations of central nervous system neurons, including cholinergic and dopaminergic neurons. In addition, neurotrophins, particularly BDNF, may regulate LTP in the hippocampus and influence synaptic plasticity. The purpose of this study was to test the hypothesis that ketamine use in humans is associated with altered serum levels of neurotrophins. We measured by enzyme-linked immunosorbent assay the NGF and BDNF serum levels in two groups of subjects: frequent ketamine users and healthy subjects. Our data show that BDNF serum levels were increased in chronic ketamine users as compared to healthy subjects, while NGF levels were not affected by ketamine use. These findings suggest that chronic ketamine intake is associated with increases in BDNF serum levels in humans. Other studies are needed to explore the pharmacological and molecular mechanism by which ketamine, and/or other NMDA antagonists, may induce modification in the production and utilization of BDNF and alter normal brain function.
引用
收藏
页码:143 / 148
页数:6
相关论文
共 53 条
[1]  
ADAMS B, 1998, BIOL PSYCHIAT, V18, P811
[2]   Reduced serum concentrations of nerve growth factor, but not brain-derived neurotrophic factor, in chronic cannabis abusers [J].
Angelucci, Francesco ;
Ricci, Valerio ;
Spalletta, Gianfranco ;
Pomponi, Massimiliano ;
Tonioni, Federico ;
Caltagirone, Carlo ;
Bria, Pietro .
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2008, 18 (12) :882-887
[3]   Chronic heroin and cocaine abuse is associated with decreased serum concentrations of the nerve growth factor and brain-derived neurotrophic factor [J].
Angelucci, Francesco ;
Ricci, Valerio ;
Pomponi, Massimiliano ;
Conte, Gianluigi ;
Mathe, Aleksander A. ;
Tonali, Pietro Attilio ;
Bria, Pietro .
JOURNAL OF PSYCHOPHARMACOLOGY, 2007, 21 (08) :820-825
[4]   Chronic amphetamine treatment reduces NGF and BDNF in the rat brain [J].
Angelucci, Francesco ;
Gruber, Susanne H. M. ;
El Khoury, Aram ;
Tonali, Pietro Attilio ;
Mathe, Aleksander A. .
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2007, 17 (12) :756-762
[5]   Ecstasy (MDMA)-addicted subjects show increased serum levels of brain-derived neurotrophic factor, independently from a rise of drug-induced psychotic symptoms [J].
Angelucci, Francesco ;
Ricci, Valerio ;
Martinotti, Giovanni ;
Palladino, Ilaria ;
Spalletta, Gianfranco ;
Caltagirone, Carlo ;
Bria, Pietro .
ADDICTION BIOLOGY, 2010, 15 (03) :365-367
[6]   EFFECTS OF PSYCHOSTIMULANTS ON NEUROTROPHINS: IMPLICATIONS FOR PSYCHOSTIMULANT-INDUCED NEUROTOXICITY [J].
Angelucci, Francesco ;
Ricci, Valerio ;
Spalletta, Gianfranco ;
Caltagirone, Carlo ;
Mathe, Aleksander A. ;
Bria, Pietro .
NEW CONCEPTS OF PSYCHOSTIMULANTS INDUCED NEUROTOXICITY, 2009, 88 :1-24
[7]  
ANIS NA, 1983, BRIT J PHARMACOL, V83, P179
[8]   Expression of mRNA of neurotrophic factors and their receptors are significantly altered after subchronic ketamine treatment [J].
Becker, Axel ;
Grecksch, Gisela ;
Schwegler, Herbert ;
Roskoden, Thomas .
MEDICINAL CHEMISTRY, 2008, 4 (03) :256-263
[9]   Antidepressant effects of ketamine in depressed patients [J].
Berman, RM ;
Cappiello, A ;
Anand, A ;
Oren, DA ;
Heninger, GR ;
Charney, DS ;
Krystal, JH .
BIOLOGICAL PSYCHIATRY, 2000, 47 (04) :351-354
[10]   THE GLYCINE NMDA RECEPTOR ANTAGONIST, R-(+)-HA-966, BLOCKS ACTIVATION OF THE MESOLIMBIC DOPAMINERGIC SYSTEM INDUCED BY PHENCYCLIDINE AND DIZOCILPINE (MK-801) IN RODENTS [J].
BRISTOW, LJ ;
HUTSON, PH ;
THORN, L ;
TRICKLEBANK, MD .
BRITISH JOURNAL OF PHARMACOLOGY, 1993, 108 (04) :1156-1163